Xenon Pharmaceuticals Inc.

(NASDAQ: XENE) Trade

By |

Equities News

Company chart and information is provided by TradingView based on 15-minute-delayed data.


Profile

Xenon Pharmaceuticals Inc is a clinical-stage biopharmaceutical company committed to developing innovative therapeutics to improve the lives of patients with neurological disorders, including the rare central nervous system, or CNS, conditions. The product candidates of the group include XEN1101, XEN901 and XEN496 for Epilepsy, XEN007 for Orphan neurological, and Nav1.7 oral inhibitors for Pain. Geographically the activities are carried out through Canada.

Contact Information

Website: www.xenon-pharma.com
Email: investors@xenon-pharma.com
Main Phone: +1 604 484-3300
Address: 200-3650 Gilmore Way
State: BC
City / Town: Burnaby
Country: CA
Postal Code: V5G 4W8

Issuer Information

Exchange: NSD
CEO: Simon Pimstone
Employees: 129
NAICS: Pharmaceutical Preparation Manufacturing(325412)

Equities News

(%)
Company data no longer available
Last Price N/A Change $ N/A Change % N/A Tick N/A
Bid N/A Bid Size N/A Ask N/A Ask Size N/A
Open N/A High N/A Low N/A Prev Close N/A
Last Trade Volume N/A 52 Wk Hi N/A 52 Wk Low N/A
Market Cap N/A Ex-Div Date N/A Div Rate N/A Yield N/A
Shares N/A EPS (TTM) N/A PE Ratio N/A Exchange N/A